Is IMDX or ISPC more undervalued in 2026?

CirclFi compares Insight Molecular Diagnostics I (IMDX) and iSpecimen Inc. (ISPC) using 13 institutional-grade valuation models. IMDX has a Quality of Company score of 5.3/10 while ISPC scores 4.5/10.

Which is a better buy — IMDX or ISPC?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do IMDX and ISPC valuations compare?

IMDX at $6.53 and ISPC at $3.32 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

IMDX vs ISPC Valuation Comparison 2026 — Intrinsic Value Analysis

IMDX

Diagnostics & Research

Insight Molecular Diagnostics I

Quality

5.3

out of 10

Value Trap

SAFE

Price

$6.53

Last close

Models

10/13

Active

ISPC

Diagnostics & Research

iSpecimen Inc.

Quality

4.5

out of 10

Value Trap

WARN

Price

$3.32

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	IMDX Fair Value	IMDX Upside	ISPC Fair Value	ISPC Upside
Bayesian DCF	Intrinsic	$2.19	-66.5%	$1.88	-43.2%
Earnings Power Value	Intrinsic	$1.19	-71.6%	$24.08	+328.5%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for IMDX vs ISPC — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

IMDX vs ISPC — Which Stock Is More Undervalued?

IMDX scores higher with a 5.3/10 quality rating vs ISPC's 4.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Insight Molecular Diagnostics I (IMDX) and iSpecimen Inc. (ISPC) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

IMDX currently trades at $6.53 with a QOC of 5.3/10, while ISPC trades at $3.32 with a QOC of 4.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).